Besides presence in circulation, CTCs are identified with a number of surface markers, among which CXCR4, the receptor for stromal cell -derived factor-1 (SDF-1), is the best characterized one in different types of cancer [5–7]. This evidence concerns the gene CXCR4 and cancer.